Henrietta T Doe's research while affiliated with Nagasaki University and other places

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (1)


Expression of PD-1/LAG-3 and cytokine production by CD4(+) T cells during infection with Plasmodium parasites
  • Article

December 2015

·

40 Reads

·

24 Citations

Microbiology and Immunology

Henrietta T Doe

·

·

Mana Miyakoda

·

[...]

·

Katsuyuki Yui

CD4(+) T cells play critical roles in protection against the blood-stage of malaria infection, but their uncontrolled activation can be harmful to the host. We compared the expression of inhibitory receptors on activated CD4(+) T cells and their cytokine production using rodent models of Plasmodium parasites, and compared them with those from a bacterial and another protozoan infection. CD4(+) T cells from mice infected with P. yoelii 17XL, P yoelii 17XNL, P. chabaudi, P. vinckei, and P. berghei expressed the inhibitory receptors, PD-1 and LAG-3 as early as 6 days after infection, while those from either Listeria monocytogenes or Leishmania major-infected mice did not. In response to T-cell receptor stimulation, CD4(+) T cells from mice infected with all the pathogens under study produced high levels of IFN-γ. IL-2 production was reduced in mice infected with Plasmodium species, but not with Listeria or Leishmania. In vitro blockade of the interaction between PD-1 and its ligands resulted in increased IFN-γ production in response to Plasmodium antigens, implying that PD-1 expressed on activated CD4(+) T cells actively inhibit T cell immune responses. Studies using Myd88(-/-) , Trif(-/-) , and Irf3(-/-) mice showed that the induction of these CD4(+) T cells and their ability to produce cytokines was largely independent of toll-like receptor signaling. These studies suggest that the expression of the inhibitory receptors, PD-1 and LAG-3 on CD4(+) T cells and their reduced IL-2 production are common characteristic features of Plasmodium infection.

Share

Citations (1)


... [173][174][175][176] LAG-3 has thus become one of the most critical new targets of cancer immunotherapy and is considered a major development direction after PD-1 with great application prospects. 171,177,178 Relatlimab, the first inhibitor of LAG-3 to enter the clinic, blocks the interaction of LAG-3 with MHC II. 179 RELATIVITY 047 (CA224-047), a phase II/III clinical study, was designed to evaluate a fixeddose combination of relatlimab combined with nivolumab versus nivolumab monotherapy in patients with previously untreated metastatic or unresectable melanoma. ...

Reference:

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Expression of PD-1/LAG-3 and cytokine production by CD4(+) T cells during infection with Plasmodium parasites
  • Citing Article
  • December 2015

Microbiology and Immunology